DAVID KNORR: Open Payments
NPI 1255310850 · PALMYRA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,060 in 71 payments from 18 companies in 2025. Trend: 2023 $698 · 2024 $933 · 2025 $1,060
Food & beverage: $1,060
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $211 |
| AstraZeneca Pharmaceuticals LP | 9 | $188 |
| Novo Nordisk Inc | 13 | $146 |
| Otsuka America Pharmaceutical, Inc. | 3 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Amgen Inc. | 3 | $49 |
| Axsome Therapeutics, Inc. | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 1 | $33 |
| PFIZER INC. | 2 | $32 |
Products named: VRAYLAR, BREZTRI, REXULTI, Wegovy, AIRSUPRA, CAPLYTA, Ozempic, JARDIANCE.
Industry payments across MO — which companies pay providers there.
